Everolimus in advanced/metastatic renal cell carcinoma in adults after sunitinib progression

被引:0
|
作者
Martin-Vila, A. [1 ]
Alvarez-Payero, M. [1 ]
Martinez-Lopez de Castro, N. [1 ]
Suarez-Santamaria, M. [1 ]
Castro-Dominguez, J. M. [1 ]
Ascunce-Saldana, M. D. P. [1 ]
机构
[1] Hosp Meixoeiro, Complexo Hosp Univ Vigo, Vigo, Spain
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:907 / 907
页数:1
相关论文
共 50 条
  • [31] Pulmonary artery thrombosis mimicking disease progression in metastatic renal cell carcinoma on Sunitinib
    Ahmad, M.
    Prasad, S. V. S. S.
    Krishna, M., V
    Lavingia, V
    INDIAN JOURNAL OF CANCER, 2016, 53 (01) : 112 - 113
  • [32] MiRNAs associated with time to progression in metastatic renal cell carcinoma patients treated with sunitinib
    Merhautova, J.
    Hezova, R.
    Poprach, A.
    Svoboda, M.
    Demlova, R.
    Slaby, O.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S505 - S505
  • [33] Sunitinib in the treatment of advanced renal cell carcinoma
    Drab-Mazur, Iwona
    ONCOLOGY IN CLINICAL PRACTICE, 2014, 10 : A43 - A44
  • [34] Sunitinib treatment for advanced renal cell carcinoma
    Stanislawiak-Rudowicz, Joanna
    ONCOLOGY IN CLINICAL PRACTICE, 2014, 10 : A17 - A18
  • [35] Sunitinib for the management of advanced renal cell carcinoma
    Escudier, Bernard
    EXPERT REVIEW OF ANTICANCER THERAPY, 2010, 10 (03) : 305 - 317
  • [36] Everolimus: the first approved product for patients with advanced renal cell cancer after sunitinib and/or sorafenib
    Coppin, Chris
    BIOLOGICS-TARGETS & THERAPY, 2010, 4 : 91 - 101
  • [37] Noninfectious Pneumonitis after Everolimus Therapy for Advanced Renal Cell Carcinoma
    White, Dorothy A.
    Camus, Philippe
    Endo, Masahiro
    Escudier, Bernard
    Calvo, Emiliano
    Akaza, Hideyuki
    Uemura, Hirotsugu
    Kpamegan, Euloge
    Kay, Andrea
    Robson, Matthew
    Ravaud, Alain
    Motzer, Robert J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 182 (03) : 396 - 403
  • [38] Efficacy of Temsirolimus after Previous Treatment with Sunitinib, Sorafenib or Everolimus in Advanced Renal Cell Cancer
    Grundbichler, Michael
    Mlineritsch, Brigitte
    Ressler, Sigrun
    Moik, Martin
    Kappacher, Andrea
    Rosenlechner, Sabine
    Greil, Richard
    ONCOLOGY, 2011, 80 (1-2) : 34 - 41
  • [39] Re: Sunitinib Alone or after Nephrectomy in Metastatic Renal-cell Carcinoma
    Staehler, Michael
    Battle, Dena
    Bex, Axel
    Hammers, Hans
    George, Daniel
    EUROPEAN UROLOGY, 2018, 74 (06) : 842 - 843
  • [40] Current options for the treatment of locally advanced and metastatic renal cell carcinoma: focus on sunitinib
    Ravaud, Alain
    EJC SUPPLEMENTS, 2007, 5 (07): : 4 - 11